Anticholinergic medications for reducing drooling in children with developmental disability
- Dev Med Child Neurol. 2020 Mar;62(3):346-353. doi: 10.1111/dmcn.14350.
Affiliations
- 1. Neurodisability and Rehabilitation, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
- 2. Department of Neurodevelopment and Disability, Royal Children's Hospital, Melbourne, Victoria, Australia.
- 3. Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
PMID: 31495925
DOI: 10.1111/dmcn.14350
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: mAChRResearch Areas: Neurological Disease